Study | Cardiovascular Comorbidities | Number of Patients/Controls | Relative Risk | Population/ Type of Study | ||
Abuabara et al., 2010 [30] | Cardiovascular death | Severe psoriasis: 3603; Controls: 14,330 | Hazard ratio: 1.57 (95% CI 1.26 - 1.96) | United Kingdom/ Cohort study | ||
Ahlehoff et al., 2011 [5] | Composite endpoint (myocardial infarction, stroke and cardiovascular death) | Mild psoriasis: 34,371; Severe psoriasis: 2621; Controls: 4,003,265 | Rate ratio: Composite endpoint: Mild psoriasis: 1.20 (95% CI 1.14 - 1.25); Severe psoriasis: 1.58 (95% CI 1.36 - 1.82); Stroke: Mild psoriasis: 1.25 (95% CI 1.16 - 1.33); Severe psoriasis: 1.71 (95% CI 1.39 - 2.11); Myocardial infarction: Mild psoriasis: 1.22 (95% CI 1.12 - 1.33); Severe psoriasis: 1.45 (95% CI 1.10 - 1.90); Cardiovascular death: Mild psoriasis: 1.14 (95% CI 1.06 - 1.22); Severe psoriasis 1.57 (95% CI 1.27 - 1.94) | Denmark/Cohort study | ||
Ahlehoff et al., 2011 [42] | Composite cardiovascular endpoint (recurrent myocardial infarction, stroke and cardiovascular death) after first time myocardial infarction | Patients with first time myocardial infarction; Psoriasis: 462; Controls: 48,935 | Hazard ratio: 1.26 (95% CI 1.06 - 1.54) | Denmark/Cohort study | ||
Ahlehoff et al., 2012 [38] | Ischemic stroke | Mild psoriasis: 36,765; Severe psoriasis: 2793; Controls: 4,478,926 | Rate ratio: Age < 50 years: Mild psoriasis: 1.97 (95% CI 1.66 - 2.34); Severe psoriasis: 2.80 (95% CI 1.81 - 4.34); Age ≥ 50 years: Mild psoriasis: 1.13 (95% CI 1.04 - 1.21); Severe psoriasis: 1.34 (95% CI 1.04 - 1.71) | Denmark/Cohort study | ||
Gelfand et al., 2009 [2] | Stroke | Mild psoriasis: 129,143 (controls: 496,666); Severe psoriasis: 3603 (controls 14,330) | Hazard ratio: Mild psoriasis: 1.06 (95% CI 1.0 - 1.1); Severe psoriasis: 1.43 (95% CI 1.1 - 1.9) | United Kingdom/Cohort study | ||
Kaye et al., 2008 [11] | Myocardial infarction Stroke | Psoriasis: 44,164; Controls: 219,784 | Hazard ratio: Myocardial infarction: 1.21 (95% CI 1.10 - 1.32); Stroke: 1.12 (95% CI 1.00 - 1.25) | United Kingdom/Cohort study | ||
Lai et al., 2016 [25] | Myocardial infarction Ischemic heart disease Stroke | Psoriasis: 520; Total subjects: 19,065 | Odds ratio: Myocardial infarction: 2.24 (95% CI 1.27 - 3.95); Ischemic heart disease: 1.90 (95% CI 1.18 - 3.05); Stroke: 1.01 (95% CI 0.48 - 2.16) | United States/ Cross-sectional study | ||
Lan et al., 2012 [54] | Cerebrovascular disease | Psoriasis: 8180; Controls: 163,600 | Hazard ratio: 1.28 (95% CI 1.162 - 1.413) | Taiwan/Retrospective cohort study | ||
Levesque et al., 2013 [27] | Myocardial infarction | Psoriasis: 31,421; Controls: 31,421 | Hazard ratio: 1.17 (95% CI 1.04 - 1.31) | Canada/Retrospective cohort study | ||
Li et al., 2012 [26] | Nonfatal cardiovascular disease (nonfatal myocardial infarction, nonfatal stroke) | Participants: 96,008 (women); Psoriasis: 2463 | Hazard ratio: Myocardial infarction: 1.70 (95% CI 1.01 - 2.86); Stroke: 1.45 (95% CI 0.80 - 2.65) | United States/Cohort study | ||